You are currently viewing a new version of our website. To view the old version click .

Targets, Volume 3, Issue 4

December 2025 - 4 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

  • Article
  • Open Access
148 Views
27 Pages

30 October 2025

Although traditionally contraindicated, the coadministration of tamoxifen and estradiol may hold clinical relevance in specific contexts, particularly in breast cancer survivors with premature menopause and a high risk of osteoporosis, thereby justif...

  • Review
  • Open Access
1 Citations
450 Views
28 Pages

17 October 2025

Extracellular Vesicle-associated microRNAs (EV-miRNAs) are emerging as pivotal regulators of corneal health and disease, holding exceptional promise for transforming both diagnostics and therapeutics. These vesicles carry distinct miRNA signatures in...

  • Review
  • Open Access
592 Views
35 Pages

14 October 2025

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. This review explains the connections between the genesis and progression of GBM and particular cellular tumorigenic mechanisms, such as angiogenesis, invasion, migr...

  • Review
  • Open Access
1,712 Views
28 Pages

The Expanding E3 Ligase-Ligand Landscape for PROTAC Technology

  • Zhenzhen Li,
  • Xiaoli Huang,
  • Xuchi Zhao,
  • Yunxiu Zhang and
  • Ping Li

27 September 2025

Proteolysis-targeting chimeras (PROTACs) are a transformative therapeutic modality that co-opts the ubiquitin-proteasome system for selective protein degradation. To date, the development of PROTACs has been overwhelmingly dominated by the recruitmen...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Targets - ISSN 2813-3137Creative Common CC BY license